All News #Library
Rare Diseases
Precigen Spotlights RRP Therapy Momentum at JP. Morgan Conference
12 Jan 2026 //
PR NEWSWIRE
Precigen Reveals PAPZIMEOS, Sustains Durable Responses
13 Oct 2025 //
PR NEWSWIRE
US FDA Approves First Therapy for Rare Respiratory Disease
18 Aug 2025 //
PR NEWSWIRE
Precigen & RRP Foundation to Host 2025 RRP Awareness Day on June
16 Apr 2025 //
PR NEWSWIRE
FDA Grants Priority Review To Precigen`s PRGN-2012 For RRP
25 Feb 2025 //
PR NEWSWIRE
Precigen Receives Orphan Drug Designation for PRGN-2012
16 Jan 2024 //
PR NEWSWIRE
Precigen Receives FDA Orphan Drug Designation for PRGN-2012 AdenoVerse
18 Mar 2021 //
PRNEWSWIRE

Market Place
Sourcing Support